Correction: p53 and metabolism: from mechanism to therapeutics

Fernando M. Simabuco; Mirian G. Morale; Isadora C.B. Pavan; Ana P. Morelli; Fernando R. Silva; Rodrigo E. Tamura

doi:10.18632/oncotarget.26181

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: p53 and metabolism: from mechanism to therapeutics

PDF | How to cite

Oncotarget. 2018; 9:34030-34030. https://doi.org/10.18632/oncotarget.26181

Metrics: PDF 1803 views | ?

Fernando M. Simabuco¹, Mirian G. Morale^2,3, Isadora C.B. Pavan¹, Ana P. Morelli¹, Fernando R. Silva¹ and Rodrigo E. Tamura⁴

¹ Laboratory of Functional Properties in Foods, School of Applied Sciences (FCA), Universidade de Campinas (UNICAMP), Limeira, São Paulo, Brazil
² Center for Translational Investigation in Oncology/LIM24, Instituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Brazil
³ Department of Radiology and Oncology, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil
⁴ Universidade Federal de São Paulo, Departamento de Ciências Biólogicas, Diadema, SP, Brazil

Published: September 21, 2018

This article has been corrected: The correct author affiliation is given below:

Rodrigo E. Tamura⁴

⁴ Universidade Federal de São Paulo, Departamento de Ciências Biólogicas, Diadema, SP, Brazil

Original article: Oncotarget. 2018; 9:23780-23823. DOI: https://doi.org/10.18632/oncotarget.25267.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26181

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: p53 and metabolism: from mechanism to therapeutics